Multicenter clinical trial of pioitazone in type 2 diabetes: impact on expression of soluble receptor for advanced glycation end-products (PioRAGE).

Trial Profile

Multicenter clinical trial of pioitazone in type 2 diabetes: impact on expression of soluble receptor for advanced glycation end-products (PioRAGE).

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 09 Dec 2010

At a glance

  • Drugs Glimepiride (Primary) ; Pioglitazone (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Acronyms PioRAGE
  • Most Recent Events

    • 09 Dec 2010 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
    • 14 Jun 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top